These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11953863)

  • 21. Enhancement of radiation response by roscovitine in human breast carcinoma in vitro and in vivo.
    Maggiorella L; Deutsch E; Frascogna V; Chavaudra N; Jeanson L; Milliat F; Eschwege F; Bourhis J
    Cancer Res; 2003 May; 63(10):2513-7. PubMed ID: 12750274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wortmannin sensitizes mammalian cells to radiation by inhibiting the DNA-dependent protein kinase-mediated rejoining of double-strand breaks.
    Chernikova SB; Wells RL; Elkind MM
    Radiat Res; 1999 Feb; 151(2):159-66. PubMed ID: 9952300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of extracellular signal-regulated kinase pathway by suramin with concomitant activation of DNA synthesis in cultured cells.
    Nakata H
    J Pharmacol Exp Ther; 2004 Feb; 308(2):744-53. PubMed ID: 14593092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphorothioate oligonucleotides bind in a non sequence-specific manner to the nucleolar protein C23/nucleolin.
    Weidner DA; Valdez BC; Henning D; Greenberg S; Busch H
    FEBS Lett; 1995 Jun; 366(2-3):146-50. PubMed ID: 7789533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase.
    Monia BP; Johnston JF; Geiger T; Muller M; Fabbro D
    Nat Med; 1996 Jun; 2(6):668-75. PubMed ID: 8640558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Terminally L-modified oligonucleotides: pairing, stability and biological properties.
    Tondelli L; Garbesi A; Morelli S; Calastretti A; Copreni E; Gong L; Nicolin A
    Anticancer Drugs; 1996 Feb; 7(2):189-94. PubMed ID: 8740724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyrimidine phosphorothioate oligonucleotides form triple-stranded helices and promote transcription inhibition.
    Xodo L; Alunni-Fabbroni M; Manzini G; Quadrifoglio F
    Nucleic Acids Res; 1994 Aug; 22(16):3322-30. PubMed ID: 8078767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of DNA double-strand break repair by the dual PI3K/mTOR inhibitor NVP-BEZ235 as a strategy for radiosensitization of glioblastoma.
    Gil del Alcazar CR; Hardebeck MC; Mukherjee B; Tomimatsu N; Gao X; Yan J; Xie XJ; Bachoo R; Li L; Habib AA; Burma S
    Clin Cancer Res; 2014 Mar; 20(5):1235-48. PubMed ID: 24366691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of high affinity basic fibroblast growth factor binding by oligonucleotides.
    Fennewald SM; Rando RF
    J Biol Chem; 1995 Sep; 270(37):21718-21. PubMed ID: 7665590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implication of DNA-dependent protein kinase in an early, essential, local phosphorylation event during end-joining of DNA double-strand breaks in vitro.
    Gu XY; Weinfeld MA; Povirk LF
    Biochemistry; 1998 Jul; 37(27):9827-35. PubMed ID: 9657696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of platelet heparitinase by phosphorothioate DNA oligonucleotides.
    Graham LD; Mitchell SM; Underwood PA
    Biochem Mol Biol Int; 1995 Oct; 37(2):239-46. PubMed ID: 8673006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factor receptors by phosphorothioate oligodeoxynucleotides.
    Rockwell P; O'Connor WJ; King K; Goldstein NI; Zhang LM; Stein CA
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6523-8. PubMed ID: 9177251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimization of antisense oligodeoxynucleotide structure for targeting bcr-abl mRNA.
    Giles RV; Spiller DG; Green JA; Clark RE; Tidd DM
    Blood; 1995 Jul; 86(2):744-54. PubMed ID: 7606003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suramin increases p53 protein levels but does not activate the p53-dependent G1 checkpoint.
    Howard SP; Park SJ; Hughes-Davies L; Coleman CN; Price BD
    Clin Cancer Res; 1996 Feb; 2(2):269-76. PubMed ID: 9816169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The radiosensitive cell line 180BR is not defective in the major DNA damage-sensing proteins.
    Lu H; Song Q; Arlett C; Lavin MF
    Cancer Res; 1998 Jan; 58(1):84-8. PubMed ID: 9426062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic evidence for the involvement of DNA ligase IV in the DNA-PK-dependent pathway of non-homologous end joining in mammalian cells.
    Wang H; Zeng ZC; Perrault AR; Cheng X; Qin W; Iliakis G
    Nucleic Acids Res; 2001 Apr; 29(8):1653-60. PubMed ID: 11292837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of phosphorothioate homo-oligodeoxynucleotides on herpes simplex virus type 2-induced DNA polymerase.
    Gao WY; Stein CA; Cohen JS; Dutschman GE; Cheng YC
    J Biol Chem; 1989 Jul; 264(19):11521-6. PubMed ID: 2544598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective inhibition of the DNA-dependent protein kinase (DNA-PK) by the radiosensitizing agent caffeine.
    Block WD; Merkle D; Meek K; Lees-Miller SP
    Nucleic Acids Res; 2004; 32(6):1967-72. PubMed ID: 15060176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polo-like kinase1, a new target for antisense tumor therapy.
    Elez R; Piiper A; Giannini CD; Brendel M; Zeuzem S
    Biochem Biophys Res Commun; 2000 Mar; 269(2):352-6. PubMed ID: 10708555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus.
    Matsukura M; Shinozuka K; Zon G; Mitsuya H; Reitz M; Cohen JS; Broder S
    Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7706-10. PubMed ID: 3499613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.